In 2012, MERS-CoV (Middle East Respiratory Syndrome Coronavirus) was found in Saudi Arabia. The early labor symptoms caused by the viruse are similar to SARS (Severe Acute Respiratory Syndrome). Therefore, MERS-CoV isRead More…
Focus on SARS-CoV-2
As we all know, a new crown pneumonia epidemic suddenly swept China at the end of 2019 and even affected the whole world. On January 30, 2020, WHO announced that the epidemicRead More…
Do You Know SARS-CoV ?
In 2002, severe acute respiratory syndrome occurred in Guangdong, China, and spread throughout the world, causing a global epidemic of infectious diseases. The culprit of this incident was SARS-CoV (Severe Acute RespiratoryRead More…
What is Coronavirus ?
Recently, a virus called SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) caused an epidemic with pneumonia as the main symptom. This SARS-CoV-2 is a coronavirus, so what exactly is a coronavirus? OverviewRead More…
Cancer Res: The Causes of Chemotherapy Resistance in Breast Cancer
According to a study recently published in Cancer Research by researchers and colleagues at the Belvich Institute of Biomedicine at the University of Barcelona, a large number of replicated chromosome regions areRead More…
Scientists Found that Potassium Ions are the Key to Controlling the Anticancer Ability of T cells
A study led by scientists at the Center for Cancer Research (CCR) at the American National Cancer Institute (NCI) has revealed a way to promote the continued growth of tumors in theRead More…
3D Bio-printing Model Changes Anti-cancer Drug Development and Anti-tumor Therapy
Researchers at the University of Minnesota have developed a way to study cancer cells, which could lead to new and more effective treatments. They have developed a new method to study theseRead More…
Nine characteristics shared by the most successful mAb
The path to finding a therapeutic antibody that leads to significant medical improvements is often complicated, long, and costly. Many criteria have to be taken into account in order to begin theRead More…
Sixteen New Tumor Drugs First Approved in 2018
In 2018, from the approval of JNJ’s apalutamide in the United States on February 14 to that of larotrectinib on November 26, a total of 16 new tumor drugs were approved forRead More…
Nat Genet：Scientists Discover New Target for Immunotherapy Following 2018 Nobel Prize for Medicine
Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of immunotherapy in oncology. According to a recent study published in the international journalRead More…